Information Journal Paper
APA:
Copy. (2017). Six-month safety data of recombinant vesicular stomatitis virus-zaire ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebocontrolled randomized study in healthy adults. JOURNAL OF INFECTIOUS DISEASES, 215(12), 1789-1798. SID. https://sid.ir/paper/684796/en
Vancouver:
Copy. Six-month safety data of recombinant vesicular stomatitis virus-zaire ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebocontrolled randomized study in healthy adults. JOURNAL OF INFECTIOUS DISEASES[Internet]. 2017;215(12):1789-1798. Available from: https://sid.ir/paper/684796/en
IEEE:
Copy, “Six-month safety data of recombinant vesicular stomatitis virus-zaire ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebocontrolled randomized study in healthy adults,” JOURNAL OF INFECTIOUS DISEASES, vol. 215, no. 12, pp. 1789–1798, 2017, [Online]. Available: https://sid.ir/paper/684796/en